Citigroup’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3 Buy
+1
New +$3 ﹤0.01% 5887
2026
Q1
– Sell
-14,945
Closed -$65.2K – 6118
2025
Q4
$65.2K Buy
14,945
+14,944
+1,494,400% +$80.7K ﹤0.01% 4488
2025
Q3
$4 Buy
+1
New +$4 ﹤0.01% 5993
2025
Q1
– Sell
-8
Closed -$19 – 5723
2024
Q4
$19 Hold
8
– – ﹤0.01% 5751
2024
Q3
$19 Sell
8
-2,685
-100% -$5.91K ﹤0.01% 5597
2024
Q2
$5.25K Sell
2,693
-773
-22% -$2.63K ﹤0.01% 5253
2024
Q1
$22.3K Buy
3,466
+813
+31% +$7.38K ﹤0.01% 5000
2023
Q4
$37.2K Buy
2,653
+2,651
+132,550% +$41.8K ﹤0.01% 4674
2023
Q3
$49 Sell
2
-820
-100% -$20.8K ﹤0.01% 5527
2023
Q2
$26.9K Sell
822
-2,209
-73% -$62.1K ﹤0.01% 4881
2023
Q1
$84.1K Buy
+3,031
New +$49.1K ﹤0.01% 4092

Other funds holding GNLX

Citigroup's GNLX Position: Q3 2026 in Review

Citigroup opened a new position in Genelux (GNLX) in Q3 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #5887 among its holdings. This is a return to the name: Citigroup previously reported a position in GNLX as recently as Q4 2025.

Citigroup first reported a position in GNLX in Q1 2023 and has held it in 11 quarters since. The position peaked at $84.1K in Q1 2023. 78 funds tracked by Wall St. Rank hold GNLX as of Q3 2026.

  • Citigroup held 1 share of Genelux worth $3 as of Q3 2026.
  • Genelux was a new Citigroup position in Q3 2026.
  • Genelux made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5887 holding.
  • Citigroup first reported a position in Genelux in Q1 2023 and has held it in 11 quarters since.
  • Citigroup's Genelux position peaked at $84.1K in Q1 2023.
  • 78 funds tracked by Wall St. Rank held Genelux as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.